Biblio

Author Title [ Type

] Year

Filters: Author is Abraham, Aby [Clear All Filters]

Journal Article

Barney AM, Danda S, Abraham A, Fouzia NA, Gowdra A, Abraham SSusan Clea, Sony M, Das S, Korula S, Mathai S, et al. Clinicogenetic Profile, Treatment Modalities, and Mortality Predictors of Gaucher Disease: A 15-Year Retrospective Study. Public Health Genomics. 2021:1-10.

Chendamarai E, Ganesan S, Alex AAbu, Kamath V, Nair SC, Nellickal AJose, Janet NBeryl, Srivastava V, Lakshmi KM, Viswabandya A, et al. Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance. PLoS One. 2015;10(3):e0121912.

Joshi G, Arthur NBeryl Jane, Geetha TS, Datari PVenkateswa, Modak K, Roy D, Chaudhury ADutta, Sundaraganesan P, Priyanka S, Na F, et al. Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysis. J Med Genet. 2023.

Kulkarni U, Arunachalam AKumar, Palani HKumar, Nair RRadhakrish, Balasundaram N, Venkatraman A, Korula A, Selvarajan S, Lionel S, Balasubramanian P, et al. Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia. Cell Transplant. 2023;32:9636897231198178.

George B, Kulkarni U, Lionel S, Devasia AJ, Aboobacker FN, Lakshmi KM, Selvarajan S, Korula A, Rose W, Varghese GM, et al. Haploidentical transplantation is feasible and associated with reasonable outcomes despite major infective complications - a single center experience from India. Transplant Cell Ther. 2021.

Benjamin ESathya Bam, Vinod E, Illangeswaran S, Rajamani BM, Vidhyadharan RThalayattu, Bagchi A, Maity A, Mohan A, Parasuraman G, Amirtham SManickam, et al. Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSC) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs. Cell Signal. 2024:111067.

Mathews V, George B, Viswabandya A, Abraham A, Ahmed R, Ganapule A, Sindhuvi E, Lakshmi KM, Srivastava A. Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts. PLoS One. 2013;8(4):e61637.

Maddali M, Kulkarni UPrakash, Ravindra N, Arunachalam AKumar, Venkatraman A, Lionel S, Manipadam MTherese, Devasia AJ, Korula A, Fouzia NA, et al. Mutation profile in BCR-ABL1-negative myeloproliferative neoplasms: A single-center experience from India. Hematol Oncol Stem Cell Ther. 2021.

Chattopadhyay S, Lionel S, Selvarajan S, Devasia AJ, Korula A, Kulkarni U, Aboobacker FN, Lakshmi KM, Srivastava A, Mathews V, et al. Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival. Ann Hematol. 2024.

Paul A, Kulkarni U, Yadav B, Aboobacker FN, Devasia AJ, Korula A, Abraham A, George B, George PV, Srivastava A. Speckle tracking echocardiography-derived left ventricular global longitudinal strain in ex-thalassaemics. PLoS One. 2023;18(11):e0293452.

George B, Balakrishnan R, S P, Lionel S, Selvarajan S, Devasia AJ, Korula A, Lakshmi KM, Aboobacker FN, Kulkarni U, et al. Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises . Clin Transplant. 2023:e15010.

Kulkarni U, Devasia AJ, Korula A, Na F, Pn N, Samoon YJ, Lakshmi KM, Abraham A, Srivastava A, Mathews V, et al. Use of non-cryopreserved peripheral blood stem cells (PBSC) is associated with adequate engraftment in patients with multiple myeloma undergoing an autologous transplant. Biol Blood Marrow Transplant. 2018.